Renal Cancer - Results from #7540

Risk of hypertension in cancer patients treated with sorafenib: An updated systematic review and meta-analysis - Abstract August 1, 2013

A generation of laparoscopic nephrectomy: Stage specific surgical and oncological outcomes for laparoscopic nephrectomy in a single centre - Abstract August 1, 2013

Three-year oncologic and renal functional outcomes after robot-assisted partial nephrectomy - Abstract August 1, 2013

Clinical consideration of percutaneous renal biopsy for renal tumor - Abstract August 1, 2013

Tumor seeding incidentally found two years after robotic-assisted radical nephrectomy for papillary renal cell carcinoma. A case report and review of the literature - Abstract August 1, 2013

Efficacy and safety of axitinib versus sorafenib in metastatic renal cell carcinoma: Subgroup analysis of Japanese patients from the Global Randomized Phase 3 AXIS trial - Abstract July 31, 2013

Evaluation of anatomic and morphologic nomogram to predict malignant and high-grade disease in a cohort of patients with small renal masses - Abstract July 31, 2013

Optimal management of renal cell carcinoma in the elderly: A review - Abstract July 31, 2013

Effect of small angiokinase inhibitor nintedanib (BIBF 1120) on QT interval in patients with previously untreated, advanced renal cell cancer in an open-label, phase II study - Abstract July 31, 2013

Prognostic value of microvascular invasion in predicting survival in renal cell carcinoma - Abstract July 29, 2013

Older renal cell cancer patients experience increased rates of venous thromboembolic events: A retrospective cohort study of SEER-Medicare data - Abstract July 29, 2013

Review on targeted treatment of patients with advanced-stage renal cell carcinoma: A medical oncologist's perspective - Abstract July 29, 2013

Robotic-assisted transperitoneal nephron-sparing surgery for small renal masses with associated surgical procedures: Surgical technique and preliminary experience - Abstract July 26, 2013

Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: A report by MSKCC and the KIRC TCGA Research Network - Abstract July 26, 2013

Active surveillance : Concept for renal cell carcinoma? - Abstract July 26, 2013

Sorafenib and everolimus in advanced clear cell renal carcinoma: A phase I/II trial of the SCRI Oncology Research Consortium - Abstract July 25, 2013

Prolonged exposure to tyrosine kinase inhibitors or early use of everolimus in metastatic renal cell carcinoma: Are the two options alike? - Abstract July 25, 2013

Extensive peritoneal carcinomatosis secondary to renal cell carcinoma with sarcomatoid and rhabdoid differentiation - Abstract July 25, 2013

Operative safety and oncologic outcome of laparoscopic radical nephrectomy for renal cell carcinoma >7 cm: A multicenter study of 222 patients - Abstract July 24, 2013

Progressive liver failure induced by everolimus for renal cell carcinoma in a 58-year-old male hepatitis B virus carrier - Abstract July 24, 2013

Page 378 of 455